Study Overview: This research is focused on understanding plasma cell dyscrasia (PCD), a group of diseases affecting blood cells, by studying patients in Zhongshan Hospital from 2007 to 2027. The study looks at patients' medical histories, treatments, and outcomes.
Eligibility: To join, participants need to have a diagnosis of PCD, such as multiple myeloma or MGUS (a condition with abnormal protein in the blood). They must have complete medical records and agree to join the study by signing a consent form. People with severe mental illness or who cannot use contraception, if needed, cannot participate.
- Duration: Data is collected from 2007 and will continue until 2027.
- Commitment: No extra visits are needed; the study uses existing hospital records.
- Type of Study: This is non-interventional, meaning no new treatments or medications will be tested.
How understandable was the trial content above?
Hard to understand
Easy to understand